期刊文献+

人脑胶质瘤GDNF基因启动子Ⅰ区H_3组蛋白乙酰化修饰情况 被引量:3

Situation of GDNF Promoter I Region in the Human Brain Glioma in H3K9Ac Modification
原文传递
导出
摘要 目的:明确GDNF启动子Ⅰ区在人脑胶质瘤中H3赖氨酸残基9位乙酰化(H3K9Ac)情况,探讨其对于GDNF在胶质瘤中表达的影响。方法:RT-PCR检测各组中GDNF mRNA的表达;建立基于Real-time PCR分析的染色质免疫共沉淀(ChIP)方法,检测12例胶质瘤与6例正常脑组织中GDNF基因启动子Ⅰ区H3组蛋白乙酰化情况。结果:Real-time PCR验证人脑胶质瘤GDNF mRNA的表达,转录水平随级别的增高而增高,且低级别组、高级别组与正常组之间存在显著的统计学差异(P<0.05)。启动子Ⅰ区的H3组蛋白乙酰化水平,正常组与低级别组和高级别组之间比较均有显著性差异(P<0.05),且低级别与高级别之间也有显著性差异。结论:在人脑胶质瘤组织中,GDNF启动子Ⅰ区发生了H3组蛋白高乙酰化修饰,这种修饰很可能会影响GDNF基因的表达。 Objective: To observe the histoneacetylation of GDNF promoter 1 region in human glioma, in order to explore the effect of methylation on the expression of GDNF in glioma. Methods: RT - PCR detection in each group GDNF mRNA expression; Based on the analysis of the Real - time PCR chromatin immune coprecipitation (CHIP) method, testing 12 cases of gliomas and 6 cases of normal brain tissue GDNF gene promoter region H3 histone acetylation situation. Results: Real - time PCR test the brain glioma GDNF mRNA expression shows that transcription level with the level of higher and higher. The low level group, high level group and normal group there was significant statistical difference (P〈0.05). The promoter I H3 histone acetylation level, there was significant difference (P〈0.05) among the normal group, low level group and high level group, and there was also significant difference between low level and high level, Conclusion: Acetylation occuerred in GDNF promoter I region might influence the expression of GDNF in glioma
出处 《现代生物医学进展》 CAS 2013年第35期6818-6821,共4页 Progress in Modern Biomedicine
基金 江苏省高校自然科学基金项目(11KJB180012) 青年科学基金项目(81101899)
关键词 胶质瘤 胶质细胞源性神经营养因子 启动子 乙酰化 Glioma GDNF Promoter I Historic
  • 相关文献

参考文献22

  • 1Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas[J]. Acta Neuropathol, 2005, 109:93. 被引量:1
  • 2Lin LF, Doherty DH, Lile JD, et al. A glial cell line de-rived nnrotro- phic factor for midbrain doparninerigie neurons[J]. Science, 1993,260 (5111): 1130-1132. 被引量:1
  • 3Collas P, Dahl JA. Chop it, ChIP it, Check it. The current status ofchr- omatin immunoprecipitation[J]. Front Biosci, 2008, 13:929-943. 被引量:1
  • 4Flanders KC, Ran RF, Lippa CF. Transforming growth factor-beta's in neurodegenerative disease[J]. Prog Neurobiol, 1998, 54:71-85. 被引量:1
  • 5Walton KM. GDNF. a novel factor with therapeutic potential for neu- rodegenerative disorders[J]. Mol Neurobiol, 1999, 19(7): 43-59. 被引量:1
  • 6Wiesenhofer B, Stockhammer G, Kostron H, et al. Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-alpha 1) are strongly expressed in human gliomas [J]. Acta Neuropathol,2000, 99(2): 131-137. 被引量:1
  • 7Courteny A. miller. Stressed and Depressed? Check Your GDNF for Epigenetic Repression[J]. Neuron, 2011, 69:188-190. 被引量:1
  • 8Grimm L, Holinski-Feder E, Teodofidis J, et aL Analysis of the human GDNF gene reveals an Inducible promoter, three exons, a triplet repeat within the 3'-UTR and alternative splice products [J]. Hum Mol Genet, 1998, 20(7): 1873-1886. 被引量:1
  • 9Baecker PA, Lee WH, Verity AN, et al. Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene [J]. Mol Brain Res, 1999:209-222. 被引量:1
  • 10Verity AN, Wyatt TL, Hajos B, et al. Regulation of Glial Cell Line- Derived Neurotrophic Factor Release from Rat C6 Glioblastoma Cells[J]. J Neuroche, 1998, 70(2): 531-539. 被引量:1

同被引文献41

  • 1Benesch M Eder HG Sovinz P Raith J Lackner H Moser A Urban C.Residual or recurrent cerebellar low-grade glioma in children after tumor resection: is re-treatment needed? A single center experience from 1983 to 2003[J].中国神经肿瘤杂志,2006,4(3):204-204. 被引量:15
  • 2Chen J, McKay RM, Parada LF. Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell,2012, 149(1): 36-47. 被引量:1
  • 3Alam R, Schultz CR, Golembieski WA,et al. PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma. Neuro Oncology,2013, 15(4):451-461. 被引量:1
  • 4Dasari VR, Kaur K,Velpula KK, et al. Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt Pathway.PLoS One, 2010,5(4): e10350. 被引量:1
  • 5Jiao Y, Killela PJ, Reitman ZJ, et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget,2012,3(7): 709-722. 被引量:1
  • 6Raghunathan A, Olar A, Vogel H,et al. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.Ann Diagn Pathol,2012,16(4):255-259. 被引量:1
  • 7Hartmann C1, Hentschel B, Wick W,et al. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol,2010,120(6):707-718. 被引量:1
  • 8Zhao J, Ma W, Zhao H. Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis. Neuro Oncol,2014,16(1):103-112. 被引量:1
  • 9Tabuse M, Ohta S, Ohashi Y,et al. Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells. Mol Cancer,2011,10: 60. 被引量:1
  • 10Quiros S, Roos WP, Kaina B. Rad51 and BRCA2-New molecular targets for sensitizing glioma cells to alkylating anticancer drugs. PLoS One,2011,6(11): e27183. 被引量:1

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部